Physician profile
George Johnson
NPI 1437130564
$1,280.10
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $270 · 2020: $479 · 2021: $267 · 2022: $214 · 2023: $23.81 · 2024: $26.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $50.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $50.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $294.83 | 2019-2022 | |
| Horizon Therapeutics Plc | $259.11 | 2020-2022 | |
| Musculoskeletal Transplant Foundation INC. | $192.48 | 2020 | |
| Paratek Pharmaceuticals, INC. | $144.51 | 2019-2021 | |
| Nevro Corp. | $117.74 | 2021-2023 | Senza |
| Pfizer INC. | $41.97 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $40.70 | 2019 | |
| Arbor Pharmaceuticals, INC. | $36.32 | 2021 | |
| Medtronic, INC. | $35.25 | 2021-2022 | |
| Kerecis Limited | $26.72 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Boston Scientific Corporation | $25.94 | 2019 | |
| Zyla Life Sciences, INC. | $22.96 | 2019 | |
| Tactile Systems Technology INC | $14.83 | 2020 | |
| Misonix INC | $14.11 | 2019 | |
| Sebela Pharmaceuticals INC. | $12.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.